A top 30 pharma company wanted full control over its global phase IV trials. But with five different CROs across Europe and Asia using different technologies, bringing that work in-house was a major challenge.
Medrio was chosen for its enterprise-grade security, validation, and compliance, without the cost and complexity of legacy systems.
In this case study, see how this top pharma utilized Medrio EDC and ePRO to:
- Standardize global data capture across all Phase IV studies
- Enable internal study management with minimal support
- Integrate EDC and ePRO for improved data visibility and analysis